The Ohio State University
Alnylam and Collaborators Publish New Pre-clinical Results with an RNAi ...MarketWatch (press release)This increase in erythropoietin was detectable out to two weeks after administration of a single dose of the RNAi therapeutic and was associated with a sustained increased in red blood cell parameters including reticulocyte count, hemoglobin and ...
